| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |